• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Obligation of User Fee Collections in FY 2010

Back to Table of Contents: FY 2010 MDUFMA Financial Reports

 

The user fees collected are expended only for costs necessary to support the process for the review of medical device applications, as defined in MDUFMA. The allowable and excludable costs for the process for the review of medical device applications are defined in Appendix D. As shown in the table 2, FDA obligated $57,187,100 from medical device user fees in FY 2010. Table 2 provides a breakout of user fee obligations by expense category.
 
Table 2
FY 2010 Medical Device User Fee Obligations by Expense Category
As of September 30, 2010
 
FY 2009
FY 2010
Personnel Compensation and Benefits
$31,601,700
$40,825,395
Travel and Transportation
$411,743
$418,913
GSA Rent
$2,056,920
$2,446,935
Communications
$221,797
$256,820
Contract Services
$10,094,444
$12,145,166
Equipment and Supplies
$2,792,848
$982,624
Other1
$123,292
$111,247
Total Obligations
$47,302,744
$57,187,100
1Other includes expense categories like printing & reproduction, and other miscellaneous expenses.
 
(More information about the costs of the process for device review, as defined in MDUFMA, begins on page 7.)
 
 
Next Section: Carryover Balances in FY 2010